Archive for July 11, 2010
FDA Panel Alert: Vivus Inc.
Vivus Inc. (VVUS), one of the three pharmaceutical companies in the race for the new anti-obesity drug, faces a review of its investigational weight loss drug, Qnexa, by an advisory panel for the U.S. Food and Drug Administration on July 15.